<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>News Releases - Boston Scientific</title>
<link>https://stage.mediaroom.com/bostonscientific/</link>
<description>Boston Scientific</description>
<item>
<title>Boston Scientific announces conference call discussing first quarter 2026 results</title>
<link>https://stage.mediaroom.com/bostonscientific/2026-03-30-Boston-Scientific-announces-conference-call-discussing-first-quarter-2026-results</link>
<description></description>
<pubDate>Mon, 30 Mar 2026 08:00:00 -0400</pubDate>
<guid>https://stage.mediaroom.com/bostonscientific/2026-03-30-Boston-Scientific-announces-conference-call-discussing-first-quarter-2026-results</guid>
</item>
<item>
<title>Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System</title>
<link>https://stage.mediaroom.com/bostonscientific/2026-03-30-Boston-Scientific-receives-FDA-clearance-for-the-Asurys-TM-Fluid-Management-System</link>
<description></description>
<pubDate>Mon, 30 Mar 2026 06:45:00 -0400</pubDate>
<guid>https://stage.mediaroom.com/bostonscientific/2026-03-30-Boston-Scientific-receives-FDA-clearance-for-the-Asurys-TM-Fluid-Management-System</guid>
<enclosure url="http://photos.prnewswire.com/prnthumb/20160203/329537LOGO" type="application/octet-stream" />
</item>
<item>
<title>CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints</title>
<link>https://stage.mediaroom.com/bostonscientific/2026-03-28-CHAMPION-AF-study-of-the-WATCHMAN-FLX-TM-Left-Atrial-Appendage-Closure-Device-as-a-first-line-therapy-for-stroke-risk-reduction-meets-all-primary-and-secondary-safety-and-efficacy-endpoints</link>
<description></description>
<pubDate>Sat, 28 Mar 2026 10:55:00 -0400</pubDate>
<guid>https://stage.mediaroom.com/bostonscientific/2026-03-28-CHAMPION-AF-study-of-the-WATCHMAN-FLX-TM-Left-Atrial-Appendage-Closure-Device-as-a-first-line-therapy-for-stroke-risk-reduction-meets-all-primary-and-secondary-safety-and-efficacy-endpoints</guid>
</item>
<item>
<title>HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism</title>
<link>https://stage.mediaroom.com/bostonscientific/2026-03-28-HI-PEITHO-trial-demonstrates-Boston-Scientific-EKOS-TM-Endovascular-System-is-superior-to-standard-of-care-for-treatment-of-acute-pulmonary-embolism</link>
<description></description>
<pubDate>Sat, 28 Mar 2026 10:38:00 -0400</pubDate>
<guid>https://stage.mediaroom.com/bostonscientific/2026-03-28-HI-PEITHO-trial-demonstrates-Boston-Scientific-EKOS-TM-Endovascular-System-is-superior-to-standard-of-care-for-treatment-of-acute-pulmonary-embolism</guid>
<enclosure url="https://mma.prnewswire.com/media/2944763/EKOS__Acoustic_Pulse_Thrombolysis_Treatment_Boston_Scientific.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology</title>
<link>https://stage.mediaroom.com/bostonscientific/2026-03-06-Boston-Scientific-to-host-investor-event-at-the-75th-Annual-Scientific-Session-of-the-American-College-of-Cardiology</link>
<description></description>
<pubDate>Fri, 06 Mar 2026 08:00:00 -0500</pubDate>
<guid>https://stage.mediaroom.com/bostonscientific/2026-03-06-Boston-Scientific-to-host-investor-event-at-the-75th-Annual-Scientific-Session-of-the-American-College-of-Cardiology</guid>
</item>
</channel>
</rss>
